house · trading 2022-08-26 → 2025-07-28
*Notional-weighted price return on disclosed buys from the last ~3 years, marked to the latest close — open positions, per-share (share counts aren't disclosed, so this is price performance, not realized $ P&L).
▮ buys · ▮ sells
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2025-07-28 | GSK | SELL | $1K–$15K | $37.45 | $50.45 2026-08-13 | -34.7% exit |
| 2022-12-05 | TSLA | SELL | $1K–$15K | $182.45 | $339.96 2026-08-13 | -86.3% exit |
| 2022-08-26 | AAPL | BUY | $1K–$15K | $163.62 | $305.26 2026-08-13 | +86.6% |
Return: buys are marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (how the stock moved after the sale, seller's perspective).
| Member | Shared tickers |
|---|---|
| Thomas H Tuberville | 3 · AAPL, TSLA, GSK |
| Thomas R Carper | 3 · AAPL, TSLA, GSK |
| Kurt Schrader | 3 · AAPL, TSLA, GSK |
| Rohit Khanna | 3 · AAPL, TSLA, GSK |
| Marjorie Taylor Mrs Greene | 3 · AAPL, TSLA, GSK |
| Roger W. Marshall | 3 · AAPL, TSLA, GSK |
| James B. Renacci | 2 · AAPL, GSK |
| Josh Gottheimer | 2 · AAPL, TSLA |
| Sheldon Whitehouse | 2 · AAPL, TSLA |
| Pat Roberts | 2 · AAPL, TSLA |
| K. Michael Conaway | 2 · AAPL, GSK |
| John Boozman | 2 · AAPL, GSK |